Page last updated: 2024-10-29

ketoconazole and Severe Combined Immunodeficiency

ketoconazole has been researched along with Severe Combined Immunodeficiency in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Severe Combined Immunodeficiency: Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirschhorn, R1
Nicknam, MN1
Eng, F1
Yang, DR1
Borkowsky, W1

Other Studies

1 other study available for ketoconazole and Severe Combined Immunodeficiency

ArticleYear
Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase- severe combined immunodeficiency.
    Journal of immunology (Baltimore, Md. : 1950), 1992, Nov-01, Volume: 149, Issue:9

    Topics: Adenosine Deaminase; Alleles; Ampicillin; Base Sequence; Chromosomes, Human, Pair 2; Concanavalin A;

1992